Impact of glucagon-like peptide 1 receptor agonists on lung function of diabetic patients: a 52 weeks clinical trial Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018
Pulmonary function of inhaled human insulin (Exubera®) in patients with type 2 diabetes: results from a 2-year study using standardized methodology Source: Eur Respir J 2006; 28: Suppl. 50, 742s Year: 2006
Pulmonary function of inhaled human insulin (Exubera®) in patients with type 1 diabetes: results from a 2-year study using standardized methodology Source: Eur Respir J 2006; 28: Suppl. 50, 613s Year: 2006
Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: long-term results of the INSIGHTS-IPF registry Source: Eur Respir J, 56 (2) 1902279; 10.1183/13993003.02279-2019 Year: 2020
Enhanced clinical improvement in pulmonary tuberculosis patients with antioxidant supplementation: a preliminary report Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003
Comment on: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 57 (3) 2004645; 10.1183/13993003.04645-2020 Year: 2021
Lung cancer in a cardiac and renal transplant recipient: potential role of cyclosporine – a case report Source: Annual Congress 2008 - Various aspects of thoracic oncology Year: 2008
Hemodynamics and response to therapy of pulmonary hypertension in patients with interstitial lung disease: Preliminary results of the "HYPID" prospective study Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment Year: 2012
Effect of low dose pirfenidone on survival and lung function decline in patients with idiopathic pulmonary fibrosis (IPF): results from a real life study Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia Year: 2021
Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019
Oral L-arginine therapy in patients with cystic fibrosis: a pilot study Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002
Reply: Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis Source: Eur Respir J, 57 (3) 2100283; 10.1183/13993003.00283-2021 Year: 2021
The relationship between lung function and blood glucose control in type 2 diabetic patients Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008
The role of lung function measurement in the diagnosing of pulmonary microangiopathy in diabetic patients Source: Annual Congress 2013 –New issues in lung function testing Year: 2013
Effects of nintedanib in patients with SSc-ILD and preserved and highly impaired lung function Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020
Increased survival in lung cancer patients with diabetes mellitus: A large cohort study Source: Annual Congress 2011 - Epidemiology of lung cancer and screening Year: 2011
Comparison of pulmonary function in diabetic patients with and without retinopathy and comparing to control group Source: Annual Congress 2009 - Respiratory physiology Year: 2009
Predictors of lung function decline: a retrospective study in COPD patients Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
Glucose tolerance, beta-cell function and insulin sensitivity in cystic fibrosis patients awaiting lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 780s Year: 2006